By: The ASCO Post Staff From: ascopost.com Patients may be less likely to return for subsequent screening mammography following a false-positive recall for additional imaging or biopsy, according to a recent study published by Miglioretti et al in the Annals of Internal Medicine. The findings raised concerns regarding the potential unintended consequences of false-positive results on the continued participation of …
Risk-Reducing Oncology Surgery: Discussing Short- and Long-Term Effects With Patients
By: Maurie Markman, MD From: medscape.com Hello. I’m Dr Maurie Markman, from City of Hope. I’ll be briefly discussing a very interesting paper, which recently appeared in the Journal of Clinical Oncology, entitled, “Costs of Cancer Prevention: Physical and Psychosocial Sequelae of Risk-Reducing Total Gastrectomy.” Clearly, the oncology community is very familiar with risk-reducing surgery. Certainly, based on the experience …
Gut Microbiome Affects GI Burden Symptom of Chemotherapy for Breast Cancer
By: Megan Garlapow, PhD From: oncologynurseadvisor.com Results from a comprehensive gastrointestinal (GI) assessment and analysis of the gut microbiome in patients with breast cancer undergoing chemotherapy indicated potential microbiome effects of the burden of GI symptoms. In this study, bacteria of the gut microbiome were correlated with GI inflammation and mucus degradation in 22 patients with breast cancer undergoing chemotherapy, …
Why is the EPA still exposing women to pesticides linked to breast cancer?
By: Jennifer Liss Ohayon From: ehn.org The EPA must update its testing to better capture the effects of pesticides on the mammary gland. This fall marks the 60th anniversary of writer and scientist Rachel Carson’s 1962 book “Silent Spring.” The book was seminal in that it sparked the modern environmental movement, a U.S. ban of DDT, and the founding of …
Effects of Breast Cancer Treatments on Cardiovascular Disease Risk Factors
By: Julie Scott, ANP-BC, AOCNP From: oncologynurseadvisor.com The survival rate of women with breast cancer has been steadily increasing each year since 2007. The 5-year survival rate for women with nonmetastatic invasive breast cancer is currently 90%.1 As survival rates have increased, studies have demonstrated that rates of cardiovascular disease in the same population have been increasing as well. This …